Beatrice Rivalta Donato Amodio Carmela Giancotta Veronica Santilli Lucia Pacillo Paola Zangari Nicola Cotugno Emma Concetta Manno Andrea Finocchi Stefania Bernardi Luna Colagrossi Leonarda Gentile Cristina Russo Carlo Federico Perno Paolo Rossi Caterina Cancrini Paolo Palma
10.3389/fimmu.2022.891274
Front Immunol
2022 Jun 21;13:891274.
apds covid19 iei sars-cov-2 activated pi3k delta syndrome (apds) long-lasting infection monoclonal antibody remdesivir
CC BY
https://pubmed.ncbi.nlm.nih.gov/35799775/
COVID-19 Drug Treatment
COVID-19 Drug Treatment Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal / therapeutic use Antibodies, Viral Humans SARS-CoV-2 Virus Shedding Antibodies, Monoclonal Antibodies, Viral
PMC9253383
35799775
Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment
2022